How to Source Nifurtimox for Pharmaceutical Formulation

Nifurtimox (Tablet, 30 mg, 120 mg) is classified under Anti Viral. It is therapeutically aligned with reference brands such as Lampit (USA). This guide highlights key sourcing factors buyers should consider when procuring high-quality Nifurtimox for formulation, R&D, or bulk manufacturing.

Product Overview: Nifurtimox is an antiprotozoal medicine used to treat parasitic infections, including Chagas disease and African trypanosomiasis (sleeping sickness). It works by generating toxic radicals inside the parasite, damaging its DNA and killing it.

1. Regulatory Compliance & Documentation

Ensure suppliers provide:

• ✔ Valid DMF (Drug Master File)
• ✔ COA (Certificate of Analysis) for each batch
• ✔ GMP, ISO, or ICH Q7 compliance certificates

2. Purity, Grade & Specification Matching

Nifurtimox must meet exact grade and purity for your dosage form:

• ✔ USP / EP / JP grade verification
• ✔ Particle size distribution check
• ✔ Residual solvent and heavy metal limits

3. Supplier Reliability & Audit History

• ✔ Positive past audit reports
• ✔ Pharma client references
• ✔ Years of proven API manufacturing experience

4. Commercial Terms: Pricing, MOQ & Flexibility

• ✔ Transparent pricing
• ✔ Pilot batch MOQ flexibility
• ✔ Volume-based discounts

5. Lead Time, Inventory & Logistics

Typical lead time for Nifurtimox is 4–6 weeks.

• ✔ Emergency dispatch options
• ✔ Regional warehousing
• ✔ Special storage if needed

6. Formulation Support

• ✔ Technical datasheets
• ✔ Sample availability
• ✔ Stability study support

Conclusion

Sourcing Nifurtimox is more than procurement—it’s a strategic partnership. With its tablet form and 30 mg, 120 mg specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.

Frequently Asked Questions For Sourcing of Nifurtimox